CONSUMER NOTICE: Cannatrek has quarantined T19 Beersheba, batch 05522FLO1, from market.
Patients should be guided to return unused medication to the pharmacy that dispensed their medication.
If you are a prescriber – Cannatrek recommends trialling your patients on T17 Yamba Flower (RRP of $135) as an alternative Sativa dominant flower.
If you are a pharmacy with units to dispense – Cannatrek will provide a full credit for the units you have and organise the return of the units back to Cannatrek.
Please contact the Cannatrek support team in facilitating the return of units:
[email protected]
1300 122 662
Cannatrek T19 ® Beersheba Flower is a sativa dominant hybrid dried medicinal cannabis flower. Each gram of dried flower contains 19% (w/w) THC (Delta-9-tetrahydrocannabinol).
Cannatrek T19 Beersheba, from the proprietary Kush Dan cultivar, is a sativa dominant hybrid with light green to golden-green colour. This elegant cultivar offers mild floral aromas with the vapor displaying fruity, sweet flavours with earthy back notes.
The T19 Beersheba is heavily trimmed for conformity. With a 10% moisture content the flower presents as fluffy with uniform moisture distribution. Buds break apart easily but do not crumble. As the flower is at a lower moisture content, the recommended vaping temperature is between 177ºC - 182ºC.
Cultivar : Kush Dan- THC : CBD ratio
19% : 1%
- Total Cannabinoids
1900mg
| Price per mg of cannabinoid | $0.08 |
|---|---|
| Price per Gram | $15.00 |
| Price per Oz (28g) | $420 |
| Size | 10g |
| Spectrum | Full |
| Cannabinoids | THC, CBC, CBCA, CBCV, CBG, CBGA, CBN, THCV |
| Terpenes | Beta Caryophyllene, Humulene, Limonene, Myrcene |
| Brand | Cannatrek |
| Origin | Israel |
Reviewed Jun 18, 2022 by Lukpryk7804
Reviewed Jun 10, 2022 by scarythongs
Reviewed May 11, 2022 by gwill82
Comments
Exactly why it's been pulled off the market, I haven't been contacted to advise me not to use it and it's obviously a hazard to inhale.
Cannatrek has quarantined T19 Beersheba, batch 05522FLO1, from market. This quarantine comes as a result of a spike in complaints regarding this particular batch and resulting internal investigations. These investigations revealed that the biomass is older than desired leading to poor presentation. Cannatrek is not willing to offer patients this batch under the Cannatrek brand. Cannatrek wants to reassure both patients and their practitioners that the medication was released meeting both TGO100 and TGO93 standards, and is thus safe for patients to inhale and eligible to remain in market. Patients should be guided to return unused medication to the pharmacy that dispensed their medication. Please utilise the Cannatrek support team in facilitating the return of units: [email protected] 1300 122 662 Cannatrek acknowledges the inconvenience caused to Clinics, health care practitioners, pharmacies and patients as a result of this quarantine. However, under the circumstances, Cannatrek believes this is the best outcome for Australian patients, the Australian Medicinal Cannabis market as a whole and for Cannatrek.
So are Cannatrek refunding or replacing this product for people like Me who wasted $149 on this health hazard. Safe to inhale You say?, sounds like You definetely love Your company. Nothing about this batch is a safe S8 Medicine, You offering to pay chemists back for their stock, what about Us poor bastards?. I've spent so long without Medical Cannabis due to issues directly related to Cannatrek through Montu. Me and many others have now had enough of this constant supply issues.